Dr. Zimmerman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
180 Harvester Dr Ste 110
Burr Ridge, IL 60527Phone+1 773-834-4064
Education & Training
- University of ChicagoFellowship, Hematology and Medical Oncology, 1992 - 1995
- McGaw Medical Center of Northwestern UniversityResidency, Internal Medicine, 1987 - 1992
- University of Illinois College of MedicineClass of 1989
Certifications & Licensure
- IL State Medical License 1991 - 2020
Publications & Presentations
PubMed
- 81 citationsBortezomib, lenalidomide, and dexamethasone with or without elotuzumab in patients with untreated, high-risk multiple myeloma (SWOG-1211): primary analysis of a random...Saad Z. Usmani, Antje Hoering, Sikander Ailawadhi, Rachael Sexton, Brea Lipe
The Lancet. Haematology. 2021-01-01 - 54 citationsA phase 1 clinical trial evaluating marizomib, pomalidomide and low-dose dexamethasone in relapsed and refractory multiple myeloma (NPI-0052-107): final study results.Andrew Spencer, Simon J. Harrison, Jeffrey A. Zonder, Ashraf Z. Badros, Jacob P. Laubach
British Journal of Haematology. 2018-01-01 - 57 citationsPhase 1 study of selinexor plus carfilzomib and dexamethasone for the treatment of relapsed/refractory multiple myeloma.Andrzej Jakubowiak, Jagoda Jasielec, Cara A. Rosenbaum, Craig E. Cole, Ajai Chari
British Journal of Haematology. 2019-05-24
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: